Triple combination targeting methyltransferase, BCL-2, and PD-1 facilitates antileukemia responses in acute myeloid leukemia.
Zhihong ZengAbhishek MaitiShelley HerbrichTianyu CaiAntonio CavazosTaylor ManzellaHelen MaKala HayesJairo MatthewsCourtney D D DiNardoNaval G DaverMarina Y KonoplevaPublished in: Cancer (2022)
Immunomodulation by targeting PD-1 enhances the therapeutic effect of combining an HMA and venetoclax in patients with AML.